TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.97
+1.39 (16.20%)
At close: Feb 5, 2026, 4:00 PM EST
9.54
-0.43 (-4.31%)
After-hours: Feb 5, 2026, 5:14 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $9.14 million as of February 5, 2026. Its market cap has increased by 291.96% in one year.
Market Cap
9.14M
Enterprise Value
6.72M
1-Year Change
291.96%
Ranking
Category
Stock Price
$9.97
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $9.14M, a decrease of -80.90%. That is a compound annual growth rate of -30.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 7.87M | 25.62% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.87M |
| SeaStar Medical Holding | 8.83M |
| CalciMedica | 8.78M |
| BiomX | 8.72M |
| XTL Biopharmaceuticals | 8.29M |
| Kiora Pharmaceuticals | 8.29M |
| Quince Therapeutics | 8.10M |
| PharmaCyte Biotech | 7.96M |